Moderna
MRNA
#1188
Rank
โ‚ฌ15.14 B
Marketcap
39,36ย โ‚ฌ
Share price
0.79%
Change (1 day)
-59.33%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ3.71 Billion

According to Moderna 's latest financial reports the company's total liabilities are โ‚ฌ3.71 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ4.13 B-34.13%
2022-12-31โ‚ฌ6.27 B-32.43%
2021-12-31โ‚ฌ9.29 B139.32%
2020-12-31โ‚ฌ3.88 B949.13%
2019-12-31โ‚ฌ0.37 B-1.97%
2018-12-31โ‚ฌ0.37 B-1.35%
2017-12-31โ‚ฌ0.38 B-30.03%
2016-12-31โ‚ฌ0.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ6.67 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ69.98 B 1,782.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ42.02 M-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.00 B 7.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ57.61 B 1,450.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.90 B-75.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ103.69 B 2,689.71%๐Ÿ‡บ๐Ÿ‡ธ USA